Old Web
English
Sign In
Acemap
>
Paper
>
P1.14-23 Resistance Mechanisms to Osimertinib Treatment in EGFR-Mutated Lung Cancer in a Real Life Cohort
P1.14-23 Resistance Mechanisms to Osimertinib Treatment in EGFR-Mutated Lung Cancer in a Real Life Cohort
2019
Christi M J Steendam
Peggy N. Atmodimedjo
Marthe S. Paats
C. van der Leest
J. von der Thusen
W. Dinjens
R.H.N. van Schaik
Hendrikus J. Dubbink
Joachim Aerts
Keywords:
Pathology
Oncology
Internal medicine
Cohort
Osimertinib
Medicine
Lung cancer
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]